WHO ICTRP trial
Ondansetron versus metoclopramide for hyperemesis gravidarum
ISRCTN00592566 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN00592566 |
|---|---|
| Public title | Ondansetron versus metoclopramide for hyperemesis gravidarum |
| Scientific title | Ondansetron versus metoclopramide For hyperemesis gravidarum: a randomized trial |
| Primary sponsor | University of Malaya (Malaysia) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | Malaysia |
| Conditions | Hyperemesis gravidarum - excessive vomiting in pregnancy Pregnancy and Childbirth Mild hyperemesis gravidarum |
| Interventions | Intervention: Participants will receive either 4mg ondansetron every 8 hours or 10mg metoclopramide every 8 hours for 24 hours intravenously. Participants will also receive standard intravenous rehydration. After 24 hours, open label… |
| Registration date | Aug 5, 2012 |
| Target size | 128 |
| Secondary IDs | 871.2 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: